Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
[Updated]Notice Regarding the Medium-Term Management Plan 2027 - Move on to the Next Stage -
Notice of Conclusion of Exclusive License Agreement of Shield Therapeutics Plc’s Iron Deficiency Treatment by Consolidated Subsidiary
[Summary]Notice Regarding the Medium-Term Management Plan 2027 - Move on to the Next Stage -
Notice of Revision of Earnings Forecast and Year-End Dividend Forecast (Dividend Increase) for Fiscal Year Ending March 31 2025
VITAL KSK, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 2% Increase, Dividend Revised Upward by 2 yen
[Delayed] Notice Regarding Change in Largest Shareholder and Acquisition of Shares Defined by Government Ordinance as an Act Equivalent to a Tender Of
VITAL KSK, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 1%, Exceeds Full-Year Plan
Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2025 (the 16th term)
Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP]
Notice Regarding Recording of Gain on Sale of Investment Securities (Extraordinary Income)
[Delayed] Notice Regarding Changes in Large and Largest Shareholders
Notice of Status of Share Repurchase and Completion of Acquisition
Notice of Status of Share Repurchase
Summary of Financial Results for the second quarter 2025
VITAL KSK HOLDINGS,INC., First Half Ordinary Profit Unexpectedly Revised Upward by 5%
Notice of Status of Share Repurchase
Notice of Status of Share Repurchase
Notice of Status of Share Repurchase